日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An Inflammation-Associated Prognostic Model for Hepatocellular Carcinoma Following Radical Resection

肝细胞癌根治性切除术后炎症相关预后模型

Zhai, Yanyun; Gan, Biling; Guan, Renguo; Lin, Ye; Lu, Yanxia

Texture-controlled growth of large-scale single-crystal metal foils

大面积单晶金属箔的织构控制生长

Wang, Yu; Zhang, Zhibin; Jia, Yilin; Ding, Min; Zhao, Chong; Wang, Qinghe; Wu, Qile; Sun, Wanting; Huang, Zhi; He, Menglin; Ding, Zhiqiang; Liang, Wei; Zhou, Kun; Zhao, Mengze; Wang, Jijun; Zhang, Run; Yue, Xiangbin; Gao, Minqiang; Guan, Renguo; Zhou, Lin; Wang, Enge; Fu, Ying; Wu, Muhong

Hepatic arterial infusion chemotherapy-based conversion hepatectomy in responders versus nonresponders with hepatocellular carcinoma: a multicenter cohort study

肝动脉灌注化疗后行转化性肝切除术治疗肝细胞癌的疗效比较:一项多中心队列研究

Deng, Min; Zhong, Chong; Li, Dong; Guan, Renguo; Lee, Carol; Chen, Huanwei; Qin, Wei; Cai, Hao; Guo, Rongping; Chen, Zubing

Oxaliplatin induces pyroptosis in hepatoma cells and enhances antitumor immunity against hepatocellular carcinoma.

奥沙利铂可诱导肝癌细胞焦亡,并增强机体对肝细胞癌的抗肿瘤免疫力

Deng Min, Zhao Rongce, Zou Hao, Guan Renguo, Wang Jiongliang, Lee Carol, He Benyi, Zhou Jing, Li Shaohua, Wei Wei, Cai Hao, Guo Rongping

Assessment of Tumor Burden Score as a Feasible and Reliable Tool for Prognosis Prediction for Hepatocellular Carcinoma Undergoing Hepatectomy: A Multicenter, Retrospective Study

肿瘤负荷评分作为肝细胞癌肝切除术预后预测的可行可靠工具的评估:一项多中心回顾性研究

Guan, Renguo; Zheng, Zehao; Deng, Min; Mei, Jie; Lin, Ye

Traditional Chinese medicine in liver cancer: a visualization and bibliometric analysis

传统中医药在肝癌治疗中的应用:可视化和文献计量分析

Li, Ming; Zhang, Renguo; Liang, Siqin; Feng, Kangkang; Tang, Yun; Qiu, Bin; Tu, Qiang

Patients with hepatocellular carcinoma extrahepatic metastases can benefit from hepatic arterial infusion chemotherapy combined with lenvatinib plus programmed death-1 inhibitors

肝细胞癌肝外转移患者可从肝动脉灌注化疗联合乐伐替尼和程序性死亡受体-1抑制剂治疗中获益。

Guan, Renguo; Zhang, Nan; Deng, Min; Lin, Ye; Huang, Guanjie; Fu, Yizhen; Zheng, Zehao; Wei, Wei; Zhong, Chong; Zhao, Haitao; Mei, Jie; Guo, Rongping

Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinoma

α-FAtE评分在肝细胞癌局部区域免疫治疗预后预测中的应用

Zheng, Zehao; Guan, Renguo; Zhao, Rongce; Gan, Junyu; Xiong, Xinhao; Zou, Jing-Wen; Li, Shaohua; Wang, Qiaoxuan; Wei, Wei; Mei, Jie; Guo, Rongping

A novel liver-function-indicators-based prognosis signature for patients with hepatocellular carcinoma treated with anti-programmed cell death-1 therapy

一种基于肝功能指标的新型预后特征,用于评估接受抗程序性细胞死亡蛋白-1治疗的肝细胞癌患者的预后。

Zheng, Zehao; Mei, Jie; Guan, Renguo; Zhang, Jiqi; Xiong, Xinhao; Gan, Junyu; Li, Shaohua; Guo, Rongping

Risk of hepatitis B virus reactivation and its effect on survival in advanced hepatocellular carcinoma patients treated with hepatic arterial infusion chemotherapy and lenvatinib plus programmed death receptor-1 inhibitors

乙型肝炎病毒再激活的风险及其对接受肝动脉灌注化疗和乐伐替尼联合程序性死亡受体-1抑制剂治疗的晚期肝细胞癌患者生存率的影响

Yang, Zhenyun; Guan, Renguo; Fu, Yizhen; Hu, Dandan; Zhou, Zhongguo; Chen, Minshan; Zhang, Yaojun